0001104659-19-015345.txt : 20190315
0001104659-19-015345.hdr.sgml : 20190315
20190315210108
ACCESSION NUMBER: 0001104659-19-015345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190311
FILED AS OF DATE: 20190315
DATE AS OF CHANGE: 20190315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bergstein Ivan
CENTRAL INDEX KEY: 0001554767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35619
FILM NUMBER: 19686544
MAIL ADDRESS:
STREET 1: C/O STEMLINE THERAPEUTICS, INC.
STREET 2: 750 LEXINGTON AVENUE, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001264587
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450522567
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: ELEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-502-2311
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
a4.xml
4
X0306
4
2019-03-11
0
0001264587
STEMLINE THERAPEUTICS INC
STML
0001554767
Bergstein Ivan
C/O STEMLINE THERAPEUTICS, INC.
750 LEXINGTON AVENUE, ELEVENTH FLOOR
NEW YORK
NY
10022
1
1
0
0
Chief Executive Officer
Common Stock
2019-03-11
4
S
0
55073
11.11
D
2664278
D
Common Stock
2019-03-12
4
S
0
2151
11.05
D
2662127
D
In connection with the vesting of 35,927 shares on March 8, 2019 and 66,571 shares on March 9, 2019, a total of 57,224 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
Reflects the weighted average sale price. The range of prices for such transaction is $11.00 to $11.55. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 2,664,278 shares, 849,700 shares are restricted stock.
Reflects the weighted average sale price. The range of prices for such transaction is $11.03 to $11.25. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 2,662,127 shares, 849,700 shares are restricted stock.
/s/ Ivan Bergstein
2019-03-15